Siebert Financial Corp.
|
Gloria E. Gebbia
|
Director, Ten Percent Owner, Member of 10% owner group |
Other type of transaction at price $ 0.00 per share. |
10 Jun 2025 |
9,697,714 |
9,697,714
(31%)
|
31%
|
|
0
|
Common Stock, $0.01 par value per share |
Siebert Financial Corp.
|
Gloria E. Gebbia
|
Director, Ten Percent Owner, Member of 10% owner group |
Other type of transaction at price $ 0.00 per share. |
10 Jun 2025 |
9,697,714 |
0
(0%)
|
31%
|
|
0
|
Common Stock, $0.01 par value per share |
Siebert Financial Corp.
|
John J. Gebbia
|
Director, CEO, Ten Percent Owner, Member of 10% owner group |
Other type of transaction at price $ 0.00 per share. |
10 Jun 2025 |
9,697,714 |
9,697,714
(31%)
|
31%
|
|
0
|
Common Stock, $0.01 par value per share |
Paymentus Holdings Inc - O...
|
Robert Palumbo
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
10 Jun 2025 |
3,602,968 |
39,410,125
|
-
|
|
-
|
Class B Common Stock |
Bausch Health Companies Inc
|
John A. Paulson
|
Director |
Purchase of securities on an exchange or from another person at price $ 5.24 per share. |
10 Jun 2025 |
1,029,098 |
28,222,267
(8%)
|
0%
|
5.2 |
5,392,474
|
Common Stock, no par value |
Bausch Health Companies Inc
|
John A. Paulson
|
Director |
Purchase of securities on an exchange or from another person at price $ 5.47 per share. |
10 Jun 2025 |
1,005,376 |
29,227,643
(8%)
|
0%
|
5.5 |
5,499,407
|
Common Stock, no par value |
Ford Motor Co.
|
William Clay Ford
|
Director, Executive Chair and Chair |
|
10 Jun 2025 |
923,531 |
15,127,046
(0%)
|
0%
|
|
0
|
Class B Stock, $0.01 par value |
Ford Motor Co.
|
William Clay Ford
|
Director, Executive Chair and Chair |
|
10 Jun 2025 |
923,531 |
412,882
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
Navitas Semiconductor Corp
|
Ranbir Singh
|
Director |
Sale of securities on an exchange or to another person at price $ 8.31 per share. |
10 Jun 2025 |
815,165 |
19,235,835
|
-
|
8.3 |
6,772,228
|
Class A Common Stock |
Commercial Vehicle Group Inc
|
James R. Ray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
805,031 |
1,070,970
(3%)
|
2%
|
|
0
|
Common Stock, $0.01 par value |
Bausch Health Companies Inc
|
John A. Paulson
|
Director |
Purchase of securities on an exchange or from another person at price $ 5.05 per share. |
10 Jun 2025 |
754,134 |
27,193,169
(7%)
|
0%
|
5.1 |
3,808,377
|
Common Stock, no par value |
Riot Platforms Inc
|
Jonathan Gibbs
|
CDCO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
583,430 |
583,430
(2%)
|
2%
|
|
0
|
Common Stock |
BeiGene Ltd - ADR
|
Xiaodong Wang
|
Director, Chair, Scientific Advisory Brd |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
542,880 |
7
|
-
|
|
-
|
Share Option (Right to Buy) |
Definitive Healthcare Corp...
|
Casey Heller
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
485,881 |
1,090,965
|
-
|
|
0
|
Class A Common Stock |
Arrive AI Inc
|
Daniel O’Toole
|
Director, Chief Executive Officer, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 13.85 per share. |
10 Jun 2025 |
434,672 |
23,143,909
|
-
|
13.8 |
6,020,207
|
Common Stock |
Palantir Technologies Inc ...
|
Shyam Sankar
|
See Remarks |
|
10 Jun 2025 |
405,000 |
2,901,853
|
-
|
|
-
|
Class B Common Stock |
Palantir Technologies Inc ...
|
Shyam Sankar
|
See Remarks |
|
10 Jun 2025 |
405,000 |
1,107,786
|
-
|
|
-
|
Class A Common Stock |
Zenas Biopharma Inc.
|
Leon Oliver Moulder
|
Director, See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
400,000 |
400,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Palantir Technologies Inc ...
|
Shyam Sankar
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
375,000 |
1,500,000
|
-
|
|
-
|
Employee Stock Option (Right to buy) |
Palantir Technologies Inc ...
|
Shyam Sankar
|
See Remarks |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
375,000 |
3,306,853
|
-
|
|
-
|
Class B Common Stock |
BeiGene Ltd - ADR
|
John V. Oyler
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
348,374 |
348,374
|
-
|
|
-
|
Share Option (Right to Buy) |
BeiGene Ltd - ADR
|
Xiaobin Wu
|
President and COO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
232,245 |
232,245
|
-
|
|
-
|
Share Option (Right to Buy) |
Greenland Technologies Hol...
|
Peter Zuguang Wang
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
10 Jun 2025 |
200,000 |
6,011,740
(43%)
|
1%
|
|
0
|
Ordinary Shares |
BeiGene Ltd - ADR
|
Xiaodong Wang
|
Director, Chair, Scientific Advisory Brd |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
185,796 |
185,796
|
-
|
|
-
|
Share Option (Right to Buy) |
BeiGene Ltd - ADR
|
John V. Oyler
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
185,055 |
8,281,841
(1%)
|
0%
|
|
0
|
Ordinary Shares |
Paymentus Holdings Inc - O...
|
Robert Palumbo
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
10 Jun 2025 |
180,352 |
2,085,166
|
-
|
|
-
|
Class B Common Stock |
Zenas Biopharma Inc.
|
Joseph Farmer
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
175,000 |
175,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Palantir Technologies Inc ...
|
Shyam Sankar
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 131.92 per share. |
10 Jun 2025 |
169,629 |
845,591
|
-
|
131.9 |
22,378,153
|
Class A Common Stock |
BeiGene Ltd - ADR
|
Lai Wang
|
Global Head of R&D |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
162,565 |
162,565
|
-
|
|
-
|
Share Option (Right to Buy) |
Paymentus Holdings Inc - O...
|
Robert Palumbo
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
10 Jun 2025 |
151,676 |
1,659,067
|
-
|
|
-
|
Class B Common Stock |
CuriosityStream Inc - Ordi...
|
John S. Hendricks
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 5.20 per share. |
10 Jun 2025 |
150,000 |
20,570,585
|
-
|
5.2 |
779,610
|
Common Stock |
Zenas Biopharma Inc.
|
Jennifer A. Fox
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
150,000 |
150,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Wheels Up Experience Inc -...
|
Gregory L. Summe
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
148,026 |
235,714
|
-
|
|
0
|
Class A Common Stock, par value $0.0001 per share |
NexPoint Diversified Real ...
|
James D. Dondero
|
Director, See Remarks, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
146,768 |
146,768
|
-
|
|
-
|
Restricted Share Units |
NexPoint Diversified Real ...
|
Matt McGraner
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
146,768 |
146,768
|
-
|
|
-
|
Restricted Share Units |
Paymentus Holdings Inc - O...
|
Jason Klein
|
Director |
Other type of transaction at price $ 0.00 per share. |
10 Jun 2025 |
146,758 |
1,294,141
|
-
|
|
-
|
Class B Common Stock |
Palantir Technologies Inc ...
|
Shyam Sankar
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 132.92 per share. |
10 Jun 2025 |
137,886 |
707,705
|
-
|
132.9 |
18,327,297
|
Class A Common Stock |
SoundHound AI Inc - Ordina...
|
Majid Emami
|
VP, Engineering, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 10.04 per share. |
10 Jun 2025 |
132,352 |
537,482
|
-
|
10.0 |
1,328,907
|
Class A Common Stock |
Celsius Holdings Inc
|
John Fieldly
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 43.06 per share. |
10 Jun 2025 |
132,171 |
1,169,380
(1%)
|
0%
|
43.1 |
5,691,283
|
Common Stock, $0.001 par value per share |
Outset Medical Inc
|
Renee M. Gaeta
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
131,425 |
131,425
|
-
|
|
0
|
Common Stock |
CuriosityStream Inc - Ordi...
|
John S. Hendricks
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 5.11 per share. |
10 Jun 2025 |
125,000 |
20,445,585
|
-
|
5.1 |
638,925
|
Common Stock |
BeiGene Ltd - ADR
|
Xiaobin Wu
|
President and COO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
123,370 |
1,274,296
(0%)
|
0%
|
|
0
|
Ordinary Shares |
BeiGene Ltd - ADR
|
Aaron Rosenberg
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
119,873 |
119,873
|
-
|
|
-
|
Share Option (Right to Buy) |
Wheels Up Experience Inc -...
|
Timothy M. Armstrong
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
115,132 |
302,835
|
-
|
|
0
|
Class A Common Stock, par value $0.0001 per share |
Wheels Up Experience Inc -...
|
Donald Lee Moak
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
115,132 |
223,597
|
-
|
|
0
|
Class A Common Stock, par value $0.0001 per share |
Nextdoor Holdings Inc - Or...
|
Dana L. Evan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
106,707 |
106,707
|
-
|
|
-
|
Restricted Stock Units (RSU) |
Nextdoor Holdings Inc - Or...
|
J. William Gurley
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
106,707 |
106,707
|
-
|
|
-
|
Restricted Stock Units (RSU) |
Nextdoor Holdings Inc - Or...
|
David Sze
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
106,707 |
106,707
|
-
|
|
-
|
Restricted Stock Units (RSU) |
Nextdoor Holdings Inc - Or...
|
Robert Hohman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
106,707 |
106,707
|
-
|
|
-
|
Restricted Stock Units (RSU) |
Nextdoor Holdings Inc - Or...
|
Elisa A. Steele
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
106,707 |
106,707
|
-
|
|
-
|
Restricted Stock Units (RSU) |
Nextdoor Holdings Inc - Or...
|
Niraj Shah
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
106,707 |
106,707
|
-
|
|
-
|
Restricted Stock Units (RSU) |
Nextdoor Holdings Inc - Or...
|
Jason Pressman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
106,707 |
106,707
|
-
|
|
-
|
Restricted Stock Units (RSU) |
Nextdoor Holdings Inc - Or...
|
Christopher Varelas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
106,707 |
106,707
|
-
|
|
-
|
Restricted Stock Units (RSU) |
Zenas Biopharma Inc.
|
Orlando Oliveira
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
100,000 |
100,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
BeiGene Ltd - ADR
|
Xiaodong Wang
|
Director, Chair, Scientific Advisory Brd |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
98,696 |
5,180,861
(0%)
|
0%
|
|
0
|
Ordinary Shares |
Mach Natural Resources LP ...
|
William W. McMullen
|
Director, Ten Percent Owner, See Remarks |
Purchase of securities on an exchange or from another person at price $ 14.29 per share. |
10 Jun 2025 |
93,500 |
74,532,539
|
-
|
14.3 |
1,336,115
|
Common Units |
Blade Air Mobility Inc - O...
|
Robert S. Wiesenthal
|
Director, Chief Executive Officer, Ten Percent Owner |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.80 per share. |
10 Jun 2025 |
91,031 |
5,762,899
|
-
|
3.8 |
345,918
|
Class A common stock, $0.0001 par value per share |
BeiGene Ltd - ADR
|
Chan Henry Lee
|
SVP, General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
88,244 |
88,244
|
-
|
|
-
|
Share Option (Right to Buy) |
BeiGene Ltd - ADR
|
Lai Wang
|
Global Head of R&D |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
86,359 |
1,058,304
(0%)
|
0%
|
|
0
|
Ordinary Shares |
Palantir Technologies Inc ...
|
Shyam Sankar
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 131.10 per share. |
10 Jun 2025 |
84,336 |
1,015,220
|
-
|
131.1 |
11,056,745
|
Class A Common Stock |
Mach Natural Resources LP ...
|
William W. McMullen
|
Director, Ten Percent Owner, See Remarks |
Purchase of securities on an exchange or from another person at price $ 13.58 per share. |
10 Jun 2025 |
79,218 |
74,366,628
|
-
|
13.6 |
1,075,780
|
Common Units |
Navitas Semiconductor Corp
|
David Moxam
|
Director |
Sale of securities on an exchange or to another person at price $ 7.90 per share. |
10 Jun 2025 |
78,649 |
0
|
-
|
7.9 |
621,532
|
Class A Common Stock |
Commercial Vehicle Group Inc
|
J. Michael Nauman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
75,472 |
161,307
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
Commercial Vehicle Group Inc
|
William C. Johnson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
75,472 |
112,733
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
Commercial Vehicle Group Inc
|
Jeffrey S. Niew
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
75,472 |
125,285
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
Commercial Vehicle Group Inc
|
Wayne M. Rancourt
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
75,472 |
233,255
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
Commercial Vehicle Group Inc
|
Ruth Gratzke
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
75,472 |
136,207
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
Commercial Vehicle Group Inc
|
Melanie K. Cook
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
75,472 |
109,557
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
CryoPort Inc
|
Edward J. Zecchini
|
Chief Digital and Tech Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
75,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
CryoPort Inc
|
Edward J. Zecchini
|
Chief Digital and Tech Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.07 per share. |
10 Jun 2025 |
75,000 |
141,911
(0%)
|
0%
|
3.1 |
230,250
|
Common Stock |
Arrive AI Inc
|
John Ritchison
|
Director |
Sale of securities on an exchange or to another person at price $ 13.85 per share. |
10 Jun 2025 |
72,500 |
1,302,500
|
-
|
13.9 |
1,004,125
|
Common Stock |
Mach Natural Resources LP ...
|
William W. McMullen
|
Director, Ten Percent Owner, See Remarks |
Purchase of securities on an exchange or from another person at price $ 14.01 per share. |
10 Jun 2025 |
72,411 |
74,439,039
|
-
|
14.0 |
1,014,478
|
Common Units |
Perdoceo Education Corpora...
|
John R. Kline
|
SVP, AIU |
Sale of securities on an exchange or to another person at price $ 31.75 per share. |
10 Jun 2025 |
71,254 |
75,868
(0%)
|
0%
|
31.8 |
2,262,315
|
Common Stock |
Insmed Inc
|
S. Nicole Schaeffer
|
Chief People Strategy Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
70,000 |
87,290
|
-
|
|
-
|
Stock Option (right to buy) |
Insmed Inc
|
S. Nicole Schaeffer
|
Chief People Strategy Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.91 per share. |
10 Jun 2025 |
70,000 |
188,579
(0%)
|
0%
|
13.9 |
973,700
|
Common Stock |
Nextdoor Holdings Inc - Or...
|
J. William Gurley
|
Director, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
68,627 |
68,627
|
-
|
|
0
|
Class A Common Stock |
Nextdoor Holdings Inc - Or...
|
J. William Gurley
|
Director, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
68,627 |
0
|
-
|
|
-
|
Restricted Stock Units (RSU) |
Nextdoor Holdings Inc - Or...
|
David Sze
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
68,627 |
68,627
|
-
|
|
0
|
Class A Common Stock |
Nextdoor Holdings Inc - Or...
|
David Sze
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
68,627 |
0
|
-
|
|
-
|
Restricted Stock Units (RSU) |
Nextdoor Holdings Inc - Or...
|
Jason Pressman
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
68,627 |
68,627
|
-
|
|
0
|
Class A Common Stock |
Nextdoor Holdings Inc - Or...
|
Jason Pressman
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
68,627 |
0
|
-
|
|
-
|
Restricted Stock Units (RSU) |
Nextdoor Holdings Inc - Or...
|
Christopher Varelas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
68,627 |
68,627
|
-
|
|
0
|
Class A Common Stock |
Nextdoor Holdings Inc - Or...
|
Christopher Varelas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
68,627 |
0
|
-
|
|
-
|
Restricted Stock Units (RSU) |
Rezolute Inc
|
Nevan Charles Elam
|
Director, CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
68,000 |
292,119
|
-
|
|
0
|
Common Shares |
Outset Medical Inc
|
Leslie L. Trigg
|
Director, Chair and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
65,103 |
123,232
|
-
|
|
0
|
Common Stock |
Arrive AI Inc
|
Neerav Shah
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 13.85 per share. |
10 Jun 2025 |
65,000 |
75,025
|
-
|
13.9 |
900,250
|
Common Stock |
Mannkind Corp
|
Steven B. Binder
|
Director |
Sale of securities on an exchange or to another person at price $ 4.00 per share. |
10 Jun 2025 |
64,085 |
925,258
(0%)
|
0%
|
4 |
256,340
|
Common Stock, $0.01 Par Value |
BeiGene Ltd - ADR
|
Aaron Rosenberg
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
63,674 |
230,802
(0%)
|
0%
|
|
0
|
Ordinary Shares |
Aldeyra Therapeutics Inc
|
Gary M. Phillips
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
62,728 |
62,728
|
-
|
|
-
|
Stock Option (Right to Buy) |
Aldeyra Therapeutics Inc
|
Martin J. Joyce
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
62,728 |
62,728
|
-
|
|
-
|
Stock Option (Right to Buy) |
Aldeyra Therapeutics Inc
|
Richard Douglas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
62,728 |
62,728
|
-
|
|
-
|
Stock Option (Right to Buy) |
Aldeyra Therapeutics Inc
|
Ben Bronstein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
62,728 |
62,728
|
-
|
|
-
|
Stock Option (Right to Buy) |
Aldeyra Therapeutics Inc
|
Neal Walker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
62,728 |
62,728
|
-
|
|
-
|
Stock Option (Right to Buy) |
Aldeyra Therapeutics Inc
|
Nancy Miller-Rich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
62,728 |
62,728
|
-
|
|
-
|
Stock Option (Right to Buy) |
AvidXchange Holdings Inc
|
Todd Cunningham
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 9.79 per share. |
10 Jun 2025 |
62,585 |
443,410
|
-
|
9.8 |
612,738
|
Common Stock |
Xilio Therapeutics Inc
|
Akintunde Bello
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
62,000 |
62,000
|
-
|
|
-
|
Stock Option (right to buy) |
Alignment Healthcare Inc
|
Robert L. Scavo
|
Chief Information Officer |
Sale of securities on an exchange or to another person at price $ 14.60 per share. |
10 Jun 2025 |
60,000 |
642,953
|
-
|
14.6 |
876,048
|
Common Stock |
Paymentus Holdings Inc - O...
|
Robert Palumbo
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
10 Jun 2025 |
59,920 |
655,425
|
-
|
|
-
|
Class B Common Stock |
Kore Group Holdings Inc
|
James E. Geisler
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
58,139 |
58,139
|
-
|
|
-
|
Restricted Stock Units |
Kore Group Holdings Inc
|
H. Paulett Eberhart
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
58,139 |
58,139
|
-
|
|
-
|
Restricted Stock Units |
Kore Group Holdings Inc
|
Timothy M. Donahue
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
58,139 |
58,139
|
-
|
|
-
|
Restricted Stock Units |
Kore Group Holdings Inc
|
Cheemin Bo-Linn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
58,139 |
58,139
|
-
|
|
-
|
Restricted Stock Units |
Amneal Pharmaceuticals Inc...
|
Gautam Patel
|
Director |
Sale of securities on an exchange or to another person at price $ 8.02 per share. |
10 Jun 2025 |
56,426 |
1,704,050
(1%)
|
0%
|
8.0 |
452,537
|
Class A Common Stock |
Akebia Therapeutics Inc.
|
Adrian Adams
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
53,600 |
53,600
|
-
|
|
-
|
Stock Option (Right to buy) |
Akebia Therapeutics Inc.
|
LeAnne M. Zumwalt
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
53,600 |
53,600
|
-
|
|
-
|
Stock Option (Right to buy) |
Akebia Therapeutics Inc.
|
Steven C. Gilman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
53,600 |
53,600
|
-
|
|
-
|
Stock Option (Right to buy) |
Akebia Therapeutics Inc.
|
Michael W. Rogers
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
53,600 |
53,600
|
-
|
|
-
|
Stock Option (Right to buy) |
Akebia Therapeutics Inc.
|
Cynthia Smith
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
53,600 |
53,600
|
-
|
|
-
|
Stock Option (Right to buy) |
Akebia Therapeutics Inc.
|
Myles Wolf
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
53,600 |
53,600
|
-
|
|
-
|
Stock Option (Right to buy) |
Akebia Therapeutics Inc.
|
Ronald E. Frieson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
53,600 |
53,600
|
-
|
|
-
|
Stock Option (Right to buy) |
OppFi Inc - Ordinary Share...
|
David Vennettilli
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
51,627 |
142,389
|
-
|
|
0
|
Class A Common Stock |
CryoPort Inc
|
Edward J. Zecchini
|
Chief Digital and Tech Officer |
Sale of securities on an exchange or to another person at price $ 6.85 per share. |
10 Jun 2025 |
51,500 |
90,411
(0%)
|
0%
|
6.8 |
352,518
|
Common Stock |
OppFi Inc - Ordinary Share...
|
Greg Zeeman
|
Director |
Sale of securities on an exchange or to another person at price $ 13.98 per share. |
10 Jun 2025 |
50,000 |
149,644
|
-
|
14.0 |
698,820
|
Class A Common Stock |
Intellicheck Inc
|
Bryan Lewis
|
Director, CEO/President |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.70 per share. |
10 Jun 2025 |
49,875 |
448,271
(2%)
|
0%
|
2.7 |
134,663
|
Common Stock, $.001 par value |
Intellicheck Inc
|
Bryan Lewis
|
Director, CEO/President |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
49,875 |
16,625
|
-
|
|
-
|
Stock Option (Right to Buy) |
Rigetti Computing Inc
|
Helene Gail Sandford
|
Director |
Sale of securities on an exchange or to another person at price $ 11.19 per share. |
10 Jun 2025 |
47,648 |
210,104
|
-
|
11.2 |
532,952
|
Common Stock |
BeiGene Ltd - ADR
|
Chan Henry Lee
|
SVP, General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
46,878 |
283,920
(0%)
|
0%
|
|
0
|
Ordinary Shares |
Waystar Holding Corp
|
Matthew J. Hawkins
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.14 per share. |
10 Jun 2025 |
46,667 |
810,798
|
-
|
4.1 |
193,201
|
Common Stock |
Waystar Holding Corp
|
Matthew J. Hawkins
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
46,667 |
1,226,214
|
-
|
|
-
|
Stock Options (right to buy) |
Nextdoor Holdings Inc - Or...
|
Dana L. Evan
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
46,033 |
46,033
|
-
|
|
0
|
Class A Common Stock |
Nextdoor Holdings Inc - Or...
|
Dana L. Evan
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
46,033 |
0
|
-
|
|
-
|
Restricted Stock Units (RSU) |
CuriosityStream Inc - Ordi...
|
John S. Hendricks
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 5.20 per share. |
10 Jun 2025 |
45,470 |
20,720,585
|
-
|
5.2 |
236,667
|
Common Stock |
Navitas Semiconductor Corp
|
Gary K. Wunderlich
|
Director |
Sale of securities on an exchange or to another person at price $ 8.11 per share. |
10 Jun 2025 |
45,219 |
243,216
|
-
|
8.1 |
366,844
|
Class A Common Stock |
UiPath Inc - Ordinary Shar...
|
Daniel Dines
|
Director, CEO and Chairman, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 13.19 per share. |
10 Jun 2025 |
45,000 |
6,138,376
|
-
|
13.2 |
593,492
|
Class A Common Stock |
GCT Semiconductor Holding ...
|
Hyunsoo Hans Shin
|
Director, Class II Director |
Purchase of securities on an exchange or from another person at price $ 1.16 per share. |
10 Jun 2025 |
45,000 |
492,248
|
-
|
1.2 |
52,200
|
Common Stock |
Ironwood Pharmaceuticals I...
|
Alexander J. Denner
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
45,000 |
211,769
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Ironwood Pharmaceuticals I...
|
Jay P. Shepard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
45,000 |
171,555
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Ironwood Pharmaceuticals I...
|
Mark G. Currie
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
45,000 |
613,419
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Ironwood Pharmaceuticals I...
|
Julie H. McHugh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
45,000 |
208,839
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Ironwood Pharmaceuticals I...
|
Andrew Dreyfus
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
45,000 |
228,313
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Ironwood Pharmaceuticals I...
|
Catherine Moukheibir
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
45,000 |
117,944
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Ironwood Pharmaceuticals I...
|
Jon R. Duane
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
45,000 |
190,339
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Ironwood Pharmaceuticals I...
|
Marla L. Kessler
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
45,000 |
165,883
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Kore Group Holdings Inc
|
James E. Geisler
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
44,776 |
81,566
|
-
|
|
0
|
Common Stock |
Kore Group Holdings Inc
|
James E. Geisler
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
44,776 |
0
|
-
|
|
-
|
Restricted Stock Units |
Kore Group Holdings Inc
|
H. Paulett Eberhart
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
44,776 |
81,566
|
-
|
|
0
|
Common Stock |
Kore Group Holdings Inc
|
H. Paulett Eberhart
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
44,776 |
0
|
-
|
|
-
|
Restricted Stock Units |
Kore Group Holdings Inc
|
Timothy M. Donahue
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
44,776 |
83,366
|
-
|
|
0
|
Common Stock |
Kore Group Holdings Inc
|
Timothy M. Donahue
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
44,776 |
0
|
-
|
|
-
|
Restricted Stock Units |
Kore Group Holdings Inc
|
Cheemin Bo-Linn
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
44,776 |
83,366
|
-
|
|
0
|
Common Stock |
Kore Group Holdings Inc
|
Cheemin Bo-Linn
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
44,776 |
0
|
-
|
|
-
|
Restricted Stock Units |
Construction Partners Inc ...
|
Ned N. Fleming
|
Director, Ten Percent Owner |
|
10 Jun 2025 |
42,857 |
85,715
|
-
|
|
-
|
Forward sale contract (obligation to sell) |
Construction Partners Inc ...
|
Ned N. Fleming
|
Director, Ten Percent Owner |
|
10 Jun 2025 |
42,857 |
128,572
|
-
|
|
-
|
Forward sale contract (obligation to sell) |
Construction Partners Inc ...
|
Ned N. Fleming
|
Director, Ten Percent Owner |
|
10 Jun 2025 |
42,857 |
171,429
|
-
|
|
-
|
Forward sale contract (obligation to sell) |
Integral Ad Science Holdin...
|
Jill Putman
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
10 Jun 2025 |
42,377 |
132,355
|
-
|
|
0
|
Common Stock, $0.001 par value |
BeiGene Ltd - ADR
|
Xiaodong Wang
|
Director, Chair, Scientific Advisory Brd |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.50 per share. |
10 Jun 2025 |
41,760 |
41,760
(0%)
|
0%
|
6.5 |
271,440
|
American Depositary Shares |
Intellicheck Inc
|
Bryan Lewis
|
Director, CEO/President |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.97 per share. |
10 Jun 2025 |
41,145 |
407,126
(2%)
|
0%
|
6.0 |
245,755
|
Common Stock, $.001 par value |
Codexis Inc.
|
Cynthia Lynne Collins
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,983 |
112,157
(0%)
|
0%
|
|
0
|
Common Stock |
Codexis Inc.
|
David V. Smith
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,983 |
105,705
(0%)
|
0%
|
|
0
|
Common Stock |
Codexis Inc.
|
Dennis P. Wolf
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,983 |
147,903
(0%)
|
0%
|
|
0
|
Common Stock |
Codexis Inc.
|
H. Stewart Parker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,983 |
143,583
(0%)
|
0%
|
|
0
|
Common Stock |
Codexis Inc.
|
Rahul Singhvi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,983 |
137,052
(0%)
|
0%
|
|
0
|
Common Stock |
Codexis Inc.
|
Christos Richards
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,983 |
85,133
(0%)
|
0%
|
|
0
|
Common Stock |
Codexis Inc.
|
Raymond de Vre
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,983 |
88,829
(0%)
|
0%
|
|
0
|
Common Stock |
Codexis Inc.
|
Esther Martinborough
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,983 |
129,036
(0%)
|
0%
|
|
0
|
Common Stock |
Alignment Healthcare Inc
|
Robert L. Scavo
|
Chief Information Officer |
Sale of securities on an exchange or to another person at price $ 15.20 per share. |
10 Jun 2025 |
40,863 |
602,090
|
-
|
15.2 |
621,207
|
Common Stock |
Transdigm Group Incorporated
|
Robert J. Small
|
Director |
Sale of securities on an exchange or to another person at price $ 1425.01 per share. |
10 Jun 2025 |
40,500 |
444,132
(0%)
|
0%
|
1425.0 |
57,712,905
|
Common Stock |
e.l.f. Beauty Inc
|
Tarang P. Amin
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
40,295 |
468,532
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
e.l.f. Beauty Inc
|
Tarang P. Amin
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
40,295 |
40,295
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
e.l.f. Beauty Inc
|
Tarang P. Amin
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
40,295 |
40,295
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
e.l.f. Beauty Inc
|
Tarang P. Amin
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
40,295 |
508,827
(1%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
Cogent Communications Hold...
|
David Schaeffer
|
Director, CHAIRMAN, CEO, AND PRESIDENT |
Sale of securities on an exchange or to another person at price $ 48.70 per share. |
10 Jun 2025 |
40,000 |
3,606,721
(7%)
|
0%
|
48.7 |
1,947,996
|
common stock |
GCT Semiconductor Holding ...
|
Hyunsoo Hans Shin
|
Director, Class II Director |
Purchase of securities on an exchange or from another person at price $ 1.20 per share. |
10 Jun 2025 |
40,000 |
447,248
|
-
|
1.2 |
48,000
|
Common Stock |
Milestone Pharmaceuticals Inc
|
Joseph C. Papa
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (right to buy) |
Milestone Pharmaceuticals Inc
|
Lisa M. Giles
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (right to buy) |
Milestone Pharmaceuticals Inc
|
Michael J. Tomsicek
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (right to buy) |
Milestone Pharmaceuticals Inc
|
Seth H.Z. Fischer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (right to buy) |
Milestone Pharmaceuticals Inc
|
Andrew R. Saik
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (right to buy) |
Milestone Pharmaceuticals Inc
|
Robert J. Wills
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (right to buy) |
Milestone Pharmaceuticals Inc
|
Stuart M. Duty
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (right to buy) |
Rezolute Inc
|
Nevan Charles Elam
|
Director, CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
40,000 |
40,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Construction Partners Inc ...
|
Ned N. Fleming
|
Director, Ten Percent Owner |
|
10 Jun 2025 |
39,417 |
181,636
|
-
|
|
-
|
Class B Common Stock |
Construction Partners Inc ...
|
Ned N. Fleming
|
Director, Ten Percent Owner |
|
10 Jun 2025 |
39,346 |
103,054
|
-
|
|
-
|
Class B Common Stock |
Construction Partners Inc ...
|
Ned N. Fleming
|
Director, Ten Percent Owner |
|
10 Jun 2025 |
39,236 |
142,400
|
-
|
|
-
|
Class B Common Stock |
Fortrea Holdings Inc
|
Edward A. Pesicka
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
38,817 |
38,817
|
-
|
|
-
|
Restricted Stock Unit |
Fortrea Holdings Inc
|
Erin L. Russell
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
38,817 |
62,763
|
-
|
|
-
|
Restricted Stock Unit |
Fortrea Holdings Inc
|
David R. Smith
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
38,817 |
38,817
|
-
|
|
-
|
Restricted Stock Unit |
Fortrea Holdings Inc
|
Amrit Ray
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
38,817 |
38,817
|
-
|
|
-
|
Restricted Stock Unit |
Insmed Inc
|
S. Nicole Schaeffer
|
Chief People Strategy Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.16 per share. |
10 Jun 2025 |
38,300 |
156,879
(0%)
|
0%
|
17.2 |
657,228
|
Common Stock |
Insmed Inc
|
S. Nicole Schaeffer
|
Chief People Strategy Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
38,300 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Insmed Inc
|
S. Nicole Schaeffer
|
Chief People Strategy Officer |
Sale of securities on an exchange or to another person at price $ 88.64 per share. |
10 Jun 2025 |
38,300 |
118,579
(0%)
|
0%
|
88.6 |
3,394,912
|
Common Stock |
Arcus Biosciences Inc
|
Patrick C. Machado
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
38,300 |
38,300
|
-
|
|
-
|
Stock Option (Right to Buy) |
Arcus Biosciences Inc
|
Kathryn E. Falberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
38,300 |
38,300
|
-
|
|
-
|
Stock Option (Rights to Buy) |
Arcus Biosciences Inc
|
Andrew J. Perlman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
38,300 |
38,300
|
-
|
|
-
|
Stock Option (Right to Buy) |
Arcus Biosciences Inc
|
David L. Lacey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
38,300 |
38,300
|
-
|
|
-
|
Stock Option (Right to Buy) |
Arcus Biosciences Inc
|
Yasunori Kaneko
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
38,300 |
38,300
|
-
|
|
-
|
Stock Option (Right to Buy) |
Arcus Biosciences Inc
|
Nicole Lambert
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
38,300 |
38,300
|
-
|
|
-
|
Stock Option (Right to Buy) |
Arcus Biosciences Inc
|
Antoni Ribas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
38,300 |
38,300
|
-
|
|
-
|
Stock Option (Right to Buy) |
Allogene Therapeutics Inc
|
Deborah M. Messemer
|
Director |
Sale of securities on an exchange or to another person at price $ 1.42 per share. |
10 Jun 2025 |
36,885 |
107,431
(0%)
|
0%
|
1.4 |
52,377
|
Common Stock |
Outset Medical Inc
|
John L. Brottem
|
General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
35,993 |
47,266
|
-
|
|
0
|
Common Stock |
Akebia Therapeutics Inc.
|
Adrian Adams
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
35,700 |
200,500
(0%)
|
0%
|
|
0
|
Common Stock |
Akebia Therapeutics Inc.
|
LeAnne M. Zumwalt
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
35,700 |
109,400
(0%)
|
0%
|
|
0
|
Common Stock |
Akebia Therapeutics Inc.
|
Steven C. Gilman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
35,700 |
152,830
(0%)
|
0%
|
|
0
|
Common Stock |
Akebia Therapeutics Inc.
|
Michael W. Rogers
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
35,700 |
161,729
(0%)
|
0%
|
|
0
|
Common Stock |
Akebia Therapeutics Inc.
|
Cynthia Smith
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
35,700 |
160,933
(0%)
|
0%
|
|
0
|
Common Stock |
Akebia Therapeutics Inc.
|
Myles Wolf
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
35,700 |
133,381
(0%)
|
0%
|
|
0
|
Common Stock |
Akebia Therapeutics Inc.
|
Ronald E. Frieson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
35,700 |
129,500
(0%)
|
0%
|
|
0
|
Common Stock |
e.l.f. Beauty Inc
|
Tarang P. Amin
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
35,434 |
549,122
(1%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
e.l.f. Beauty Inc
|
Tarang P. Amin
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
35,434 |
0
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
e.l.f. Beauty Inc
|
Tarang P. Amin
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
35,434 |
115,718
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
e.l.f. Beauty Inc
|
Tarang P. Amin
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
35,434 |
513,688
(1%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
Insmed Inc
|
S. Nicole Schaeffer
|
Chief People Strategy Officer |
Sale of securities on an exchange or to another person at price $ 91.68 per share. |
10 Jun 2025 |
35,072 |
153,507
(0%)
|
0%
|
91.7 |
3,215,401
|
Common Stock |
Haverty Furniture Cos., Inc.
|
Rawson Haverty
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
10 Jun 2025 |
35,000 |
39,523
(0%)
|
0%
|
|
0
|
Common Stock |
Haverty Furniture Cos., Inc.
|
Rawson Haverty
|
Director, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
10 Jun 2025 |
35,000 |
49,074
(3%)
|
2%
|
|
0
|
Class A Common Stock |
Insmed Inc
|
S. Nicole Schaeffer
|
Chief People Strategy Officer |
Sale of securities on an exchange or to another person at price $ 95.49 per share. |
10 Jun 2025 |
34,500 |
89,907
(0%)
|
0%
|
95.5 |
3,294,405
|
Common Stock |
CS Disco Inc
|
Scott Anthony Hill
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
34,169 |
223,230
|
-
|
|
0
|
Common Stock |
CS Disco Inc
|
Susan L. Blount
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
34,169 |
94,823
|
-
|
|
0
|
Common Stock |
CS Disco Inc
|
James R. Offerdahl
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
34,169 |
214,152
|
-
|
|
0
|
Common Stock |
CS Disco Inc
|
Colette Pierce Burnette
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
34,169 |
91,774
|
-
|
|
0
|
Common Stock |
Dolby Laboratories Inc - O...
|
Kevin J. Yeaman
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 76.22 per share. |
10 Jun 2025 |
33,504 |
114,904
(0%)
|
0%
|
76.2 |
2,553,775
|
Class A Common Stock |
ZipRecruiter Inc - Ordinar...
|
Blake J. Irving
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
32,997 |
32,997
|
-
|
|
-
|
Restricted Stock Units |
ZipRecruiter Inc - Ordinar...
|
Yvonne Hao
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
32,997 |
32,997
|
-
|
|
-
|
Restricted Stock Units |
ZipRecruiter Inc - Ordinar...
|
Mike Gupta
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
32,997 |
32,997
|
-
|
|
-
|
Restricted Stock Units |
ZipRecruiter Inc - Ordinar...
|
Cipora Herman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
32,997 |
32,997
|
-
|
|
-
|
Restricted Stock Units |
ZipRecruiter Inc - Ordinar...
|
Brie A. Carere
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
32,997 |
32,997
|
-
|
|
-
|
Restricted Stock Units |
ZipRecruiter Inc - Ordinar...
|
Emily McEvilly
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
32,997 |
32,997
|
-
|
|
-
|
Restricted Stock Units |
Uniti Group Inc
|
Harold Zeitz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
32,609 |
32,609
(0%)
|
0%
|
|
0
|
COMMON STOCK |
PaySign Inc
|
Mark R. Newcomer
|
Director, CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 5.00 per share. |
10 Jun 2025 |
31,500 |
8,670,886
(18%)
|
0%
|
5.0 |
157,516
|
Common Stock |
Talkspace Inc
|
Ian Harris
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.19 per share. |
10 Jun 2025 |
30,255 |
589,140
|
-
|
3.2 |
96,513
|
Common Stock |
ePlus Inc
|
Mark P. Marron
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
30,219 |
95,478
(0%)
|
0%
|
|
0
|
Common Stock |
Indaptus Therapeutics Inc
|
Roger J. Pomerantz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (right to buy) |
Hayward Holdings Inc
|
Eifion Jones
|
Senior Vice President and CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
30,000 |
960,375
|
-
|
|
-
|
Stock Options (Right to Buy) |
Hayward Holdings Inc
|
Eifion Jones
|
Senior Vice President and CFO |
Sale of securities on an exchange or to another person at price $ 14.31 per share. |
10 Jun 2025 |
30,000 |
287,231
|
-
|
14.3 |
429,300
|
Common Stock |
Hayward Holdings Inc
|
Eifion Jones
|
Senior Vice President and CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.40 per share. |
10 Jun 2025 |
30,000 |
317,231
|
-
|
1.4 |
42,000
|
Common Stock |
Yext Inc
|
Ho Shin
|
General Counsel |
Sale of securities on an exchange or to another person at price $ 8.63 per share. |
10 Jun 2025 |
30,000 |
112,174
(0%)
|
0%
|
8.6 |
258,831
|
Common Stock |
Outset Medical Inc
|
Marc Nash
|
SVP Operations and R&D |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
29,676 |
43,141
|
-
|
|
0
|
Common Stock |
BeiGene Ltd - ADR
|
Qingqing Yi
|
Director |
Other type of transaction at price $ 0.00 per share. |
10 Jun 2025 |
29,614 |
27,326
(0%)
|
0%
|
|
0
|
Ordinary Shares |
BeiGene Ltd - ADR
|
Titus B. Ball
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
29,601 |
73,983
(0%)
|
0%
|
|
0
|
Ordinary Shares |
NexPoint Diversified Real ...
|
Dustin Norris
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
28,980 |
28,980
|
-
|
|
-
|
Restricted Share Units |
Remitly Global Inc
|
Phillip J. Riese
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
28,598 |
28,598
|
-
|
|
-
|
Restricted Stock Units (RSUs) |
JFrog Ltd
|
Frederic Simon
|
Director |
Sale of securities on an exchange or to another person at price $ 42.39 per share. |
10 Jun 2025 |
28,100 |
4,281,803
|
-
|
42.4 |
1,191,159
|
Ordinary Shares |
World Acceptance Corp.
|
R Chad Prashad
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
28,000 |
85,584
(1%)
|
0%
|
|
0
|
COMMON STOCK, NO PAR VALUE |
Acadian Asset Management Inc.
|
Robert J. Chersi
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
27,986 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Acadian Asset Management Inc.
|
Robert J. Chersi
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
27,986 |
66,137
(0%)
|
0%
|
|
0
|
Common Stock |
ZipRecruiter Inc - Ordinar...
|
Mike Gupta
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
27,565 |
27,565
|
-
|
|
0
|
Class A Common Stock |
Autozone Inc.
|
William C. Rhodes
|
Director, Executive Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1060.81 per share. |
10 Jun 2025 |
27,500 |
39,539
(0%)
|
0%
|
1060.8 |
29,172,275
|
Common Stock |
Autozone Inc.
|
William C. Rhodes
|
Director, Executive Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
27,500 |
0
|
-
|
|
-
|
Non-Qualified Stock Option (right to buy) |
Elutia Inc - Ordinary Shar...
|
C. Randal Mills
|
Director, PRESIDENT AND CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
27,084 |
316,377
|
-
|
|
-
|
Class A Common Stock |
Elutia Inc - Ordinary Shar...
|
C. Randal Mills
|
Director, PRESIDENT AND CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
27,084 |
324,999
|
-
|
|
-
|
Restricted Stock Units |
Axogen Inc.
|
Joseph Adrian Tyndall
|
Director |
Sale of securities on an exchange or to another person at price $ 10.72 per share. |
10 Jun 2025 |
26,931 |
0
(0%)
|
0%
|
10.7 |
288,700
|
Common Stock |
Corsair Gaming Inc
|
Randall J. Weisenburger
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
26,738 |
26,738
|
-
|
|
-
|
Stock Option (Right to Buy) |
Corsair Gaming Inc
|
Jason Glenn Cahilly
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
26,738 |
26,738
|
-
|
|
-
|
Stock Option (Right to Buy) |
Corsair Gaming Inc
|
Samuel R. Szteinbaum
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
26,738 |
26,738
|
-
|
|
-
|
Stock Option (Right to Buy) |
Corsair Gaming Inc
|
Diana Bell
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
26,738 |
26,738
|
-
|
|
-
|
Stock Option (Right to Buy) |
Corsair Gaming Inc
|
Sarah Mears Kim
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
26,738 |
26,738
|
-
|
|
-
|
Stock Option (Right to Buy) |
Rezolute Inc
|
Daron Evans
|
CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
26,000 |
263,900
|
-
|
|
0
|
Common Shares |
Rezolute Inc
|
Brian Kenneth Roberts
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
26,000 |
157,352
|
-
|
|
0
|
Common Shares |
Insmed Inc
|
Martina Flammer
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
25,740 |
17,160
|
-
|
|
-
|
Stock Option (right to buy) |
Insmed Inc
|
Martina Flammer
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 88.64 per share. |
10 Jun 2025 |
25,740 |
83,111
(0%)
|
0%
|
88.6 |
2,281,594
|
Common Stock |
Insmed Inc
|
Martina Flammer
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.46 per share. |
10 Jun 2025 |
25,740 |
108,851
(0%)
|
0%
|
26.5 |
681,080
|
Common Stock |
Roku Inc - Ordinary Shares...
|
Anthony Wood
|
Director, CEO and Chairman BOD, Ten Percent Owner |
|
10 Jun 2025 |
25,000 |
25,000
(0%)
|
0%
|
|
-
|
Class A Common Stock |
Roku Inc - Ordinary Shares...
|
Anthony Wood
|
Director, CEO and Chairman BOD, Ten Percent Owner |
|
10 Jun 2025 |
25,000 |
16,878,111
|
-
|
|
-
|
Class B Common Stock |
Corcept Therapeutics Inc
|
James N. Wilson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
25,000 |
25,000
|
-
|
|
-
|
Stock option (right to buy) |
Dolby Laboratories Inc - O...
|
Kevin J. Yeaman
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
25,000 |
160,615
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Dolby Laboratories Inc - O...
|
Kevin J. Yeaman
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. |
10 Jun 2025 |
25,000 |
139,725
(0%)
|
0%
|
45.5 |
1,137,500
|
Class A Common Stock |
LiveWire Group Inc
|
William L. Cornog
|
Director |
Sale of securities on an exchange or to another person at price $ 7.65 per share. |
10 Jun 2025 |
25,000 |
211,739
|
-
|
7.7 |
191,250
|
Common Stock |
Lulus Fashion Lounge Holdi...
|
Dara Bazzano
|
Director, Board Chair |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.47 per share. |
10 Jun 2025 |
24,576 |
124,156
|
-
|
0.5 |
11,428
|
Common Stock |
Insmed Inc
|
Sara M. Bonstein
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.95 per share. |
10 Jun 2025 |
24,150 |
137,438
(0%)
|
0%
|
19.0 |
457,643
|
Common Stock |
Insmed Inc
|
Sara M. Bonstein
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
24,150 |
134,260
|
-
|
|
-
|
Stock Option (right to buy) |
NexPoint Diversified Real ...
|
Paul Richards
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
24,150 |
24,150
|
-
|
|
-
|
Restricted Share Units |
NexPoint Diversified Real ...
|
Dennis Charles Sauter
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
24,150 |
24,150
|
-
|
|
-
|
Restricted Share Units |
SIGA Technologies Inc
|
John M. Keane
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
24,116 |
24,116
|
-
|
|
-
|
Restricted Stock Units |
SIGA Technologies Inc
|
Jaymie A. Durnan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
24,116 |
24,116
|
-
|
|
-
|
Restricted Stock Units |
SIGA Technologies Inc
|
Joseph W. Marshall
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
24,116 |
24,116
|
-
|
|
-
|
Restricted Stock Units |
SIGA Technologies Inc
|
Harold E. Ford
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
24,116 |
24,116
|
-
|
|
-
|
Restricted Stock Units |
SIGA Technologies Inc
|
Julian Nemirovsky
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
24,116 |
24,116
|
-
|
|
-
|
Restricted Stock Units |
SIGA Technologies Inc
|
Gary J. Nabel
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
24,116 |
24,116
|
-
|
|
-
|
Restricted Stock Units |
SIGA Technologies Inc
|
Holly L. Phillips
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
24,116 |
24,116
|
-
|
|
-
|
Restricted Stock Units |
Insmed Inc
|
Sara M. Bonstein
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.07 per share. |
10 Jun 2025 |
23,740 |
161,178
(0%)
|
0%
|
17.1 |
405,242
|
Common Stock |
Insmed Inc
|
Sara M. Bonstein
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
23,740 |
35,610
|
-
|
|
-
|
Stock Option (right to buy) |
ZipRecruiter Inc - Ordinar...
|
Emily McEvilly
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
23,536 |
49,939
|
-
|
|
0
|
Class A Common Stock |
ZipRecruiter Inc - Ordinar...
|
Yvonne Hao
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
23,441 |
50,166
|
-
|
|
0
|
Class A Common Stock |
ACV Auctions Inc - Ordinar...
|
Michael Waterman
|
Chief Sales Officer |
Sale of securities on an exchange or to another person at price $ 16.75 per share. |
10 Jun 2025 |
22,171 |
405,610
|
-
|
16.7 |
371,364
|
Class A Common Stock |
Guess Inc.
|
Alex Yemenidjian
|
Director, Chairman of the Board |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
22,070 |
203,130
(0%)
|
0%
|
|
0
|
Common Stock |
Navitas Semiconductor Corp
|
Ranbir Singh
|
Director |
Sale of securities on an exchange or to another person at price $ 8.53 per share. |
10 Jun 2025 |
21,782 |
19,214,053
|
-
|
8.5 |
185,790
|
Class A Common Stock |
Uniti Group Inc
|
Harold Zeitz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
21,739 |
54,348
(0%)
|
0%
|
|
0
|
COMMON STOCK |
Lantern Pharma Inc
|
Leslie W. Kreis
|
Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 3.38 per share. |
10 Jun 2025 |
21,557 |
387,396
|
-
|
3.4 |
72,863
|
Common Stock |
ACV Auctions Inc - Ordinar...
|
Michael Waterman
|
Chief Sales Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.14 per share. |
10 Jun 2025 |
21,428 |
427,781
|
-
|
0.1 |
3,000
|
Class A Common Stock |
ACV Auctions Inc - Ordinar...
|
Michael Waterman
|
Chief Sales Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
21,428 |
281,264
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Metagenomi Inc.
|
Willard H. Dere
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Metagenomi Inc.
|
Juergen Eckhardt
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Insmed Inc
|
Sara M. Bonstein
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 88.99 per share. |
10 Jun 2025 |
20,926 |
125,665
(0%)
|
0%
|
89.0 |
1,862,205
|
Common Stock |
Intellicheck Inc
|
Bryan Lewis
|
Director, CEO/President |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
20,809 |
24,591
|
-
|
|
-
|
Stock Option (Right to Buy) |
Intellicheck Inc
|
Bryan Lewis
|
Director, CEO/President |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.02 per share. |
10 Jun 2025 |
20,809 |
373,411
(2%)
|
0%
|
2.0 |
42,034
|
Common Stock, $.001 par value |
ZipRecruiter Inc - Ordinar...
|
Blake J. Irving
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
20,429 |
0
|
-
|
|
-
|
Restricted Stock Units |
ZipRecruiter Inc - Ordinar...
|
Blake J. Irving
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
20,429 |
42,766
|
-
|
|
0
|
Class A Common Stock |
ZipRecruiter Inc - Ordinar...
|
Yvonne Hao
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
20,429 |
0
|
-
|
|
-
|
Restricted Stock Units |
ZipRecruiter Inc - Ordinar...
|
Cipora Herman
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
20,429 |
0
|
-
|
|
-
|
Restricted Stock Units |
ZipRecruiter Inc - Ordinar...
|
Cipora Herman
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
20,429 |
44,896
|
-
|
|
0
|
Class A Common Stock |
ZipRecruiter Inc - Ordinar...
|
Brie A. Carere
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
20,429 |
0
|
-
|
|
-
|
Restricted Stock Units |
ZipRecruiter Inc - Ordinar...
|
Brie A. Carere
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
20,429 |
49,092
|
-
|
|
0
|
Class A Common Stock |
ZipRecruiter Inc - Ordinar...
|
Emily McEvilly
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
20,429 |
0
|
-
|
|
-
|
Restricted Stock Units |
Direct Digital Holdings In...
|
Mark D. Walker
|
Director, Chairman and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
20,300 |
27,313
|
-
|
|
-
|
Class A Common Stock, par value $0.001 per share |
Direct Digital Holdings In...
|
Mark D. Walker
|
Director, Chairman and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
20,300 |
0
|
-
|
|
-
|
Restricted Stock Units |
Barinthus Biotherapeutics ...
|
Karen A. Dawes
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
20,174 |
20,174
|
-
|
|
-
|
Share Option (Right to Buy) |
Barinthus Biotherapeutics ...
|
Anne M. Phillips
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
20,174 |
20,174
|
-
|
|
-
|
Share Option (Right to Buy) |
Barinthus Biotherapeutics ...
|
Robin Wright
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
20,174 |
20,174
|
-
|
|
-
|
Share Option (Right to Buy) |
Barinthus Biotherapeutics ...
|
Alex Hammacher
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
20,174 |
20,174
|
-
|
|
-
|
Share Option (Right to Buy) |
Barinthus Biotherapeutics ...
|
Pierre A. Morgon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
20,174 |
20,174
|
-
|
|
-
|
Share Option (Right to Buy) |
Barinthus Biotherapeutics ...
|
Joseph C.F. Scheeren
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
20,174 |
20,174
|
-
|
|
-
|
Share Option (Right to Buy) |
AZEK Company Inc - Ordinar...
|
Jesse G. Singh
|
Director, CEO and President |
Sale of securities on an exchange or to another person at price $ 54.43 per share. |
10 Jun 2025 |
20,000 |
832,765
|
-
|
54.4 |
1,088,600
|
Class A Common Stock |
Grid Dynamics Holdings Inc...
|
Leonard Livschitz
|
Director, CHIEF EXECUTIVE OFFICER |
Sale of securities on an exchange or to another person at price $ 12.23 per share. |
10 Jun 2025 |
20,000 |
2,983,180
|
-
|
12.2 |
244,600
|
Common Stock |
Akari Therapeutics Plc - ADR
|
Abizer Gaslightwala
|
Director, CEO |
Grant, award, or other acquisition of securities at price $ 1.27 per share. |
10 Jun 2025 |
20,000 |
201,428
(0%)
|
0%
|
1.3 |
25,400
|
American Depositary Shares representing Ordinary Shares |
Corcept Therapeutics Inc
|
William Guyer
|
Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
20,000 |
390,000
|
-
|
|
-
|
Stock option (right to buy) |
Corcept Therapeutics Inc
|
William Guyer
|
Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.65 per share. |
10 Jun 2025 |
20,000 |
25,487
(0%)
|
0%
|
21.7 |
433,000
|
Common Stock |
Navitas Semiconductor Corp
|
Richard J. Hendrix
|
Director |
Sale of securities on an exchange or to another person at price $ 8.12 per share. |
10 Jun 2025 |
20,000 |
45,456
|
-
|
8.1 |
162,400
|
Class A Common Stock |
ZipRecruiter Inc - Ordinar...
|
Mike Gupta
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,961 |
0
|
-
|
|
-
|
Restricted Stock Units |
Procept BioRobotics Corp
|
Antal Desai
|
Director |
Sale of securities on an exchange or to another person at price $ 61.28 per share. |
10 Jun 2025 |
19,951 |
19,412
|
-
|
61.3 |
1,222,563
|
Common Stock |
Metropolitan Bank Holding ...
|
Mark R. DeFazio
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 65.33 per share. |
10 Jun 2025 |
19,873 |
97,426
(1%)
|
0%
|
65.3 |
1,298,363
|
Common Stock |
Insmed Inc
|
Martina Flammer
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,423 |
64,744
|
-
|
|
-
|
Stock Option (right to buy) |
Insmed Inc
|
Martina Flammer
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 94.50 per share. |
10 Jun 2025 |
19,423 |
83,111
(0%)
|
0%
|
94.5 |
1,835,474
|
Common Stock |
Insmed Inc
|
Martina Flammer
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.07 per share. |
10 Jun 2025 |
19,423 |
102,534
(0%)
|
0%
|
17.1 |
331,551
|
Common Stock |
SIGA Technologies Inc
|
Jaymie A. Durnan
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,084 |
77,598
(0%)
|
0%
|
|
-
|
Common Stock, par value $.0001 per share |
SIGA Technologies Inc
|
Jaymie A. Durnan
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,084 |
0
|
-
|
|
-
|
Restricted Stock Units |
SIGA Technologies Inc
|
Joseph W. Marshall
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,084 |
0
|
-
|
|
-
|
Restricted Stock Units |
SIGA Technologies Inc
|
Joseph W. Marshall
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,084 |
235,367
(0%)
|
0%
|
|
-
|
Common Stock, par value $.0001 per share |
SIGA Technologies Inc
|
Harold E. Ford
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,084 |
36,382
(0%)
|
0%
|
|
-
|
Common Stock, par value $.0001 per share |
SIGA Technologies Inc
|
Harold E. Ford
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,084 |
0
|
-
|
|
-
|
Restricted Stock Units |
SIGA Technologies Inc
|
Julian Nemirovsky
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,084 |
0
|
-
|
|
-
|
Restricted Stock Units |
SIGA Technologies Inc
|
Julian Nemirovsky
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,084 |
62,598
(0%)
|
0%
|
|
-
|
Common Stock, par value $.0001 per share |
SIGA Technologies Inc
|
Gary J. Nabel
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,084 |
62,598
(0%)
|
0%
|
|
-
|
Common Stock, par value $.0001 per share |
SIGA Technologies Inc
|
Gary J. Nabel
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,084 |
0
|
-
|
|
-
|
Restricted Stock Units |
SIGA Technologies Inc
|
Holly L. Phillips
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,084 |
0
|
-
|
|
-
|
Restricted Stock Units |
SIGA Technologies Inc
|
Holly L. Phillips
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
19,084 |
62,598
(0%)
|
0%
|
|
-
|
Common Stock, par value $.0001 per share |
Design Therapeutics Inc
|
John Schmid
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
19,000 |
19,000
|
-
|
|
-
|
Stock Option (right to buy) |
Design Therapeutics Inc
|
Rodney W. Lappe
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
19,000 |
19,000
|
-
|
|
-
|
Stock Option (right to buy) |
Design Therapeutics Inc
|
Simeon J. George
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
19,000 |
19,000
|
-
|
|
-
|
Stock Option (right to buy) |
Design Therapeutics Inc
|
Heather Berger
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
19,000 |
19,000
|
-
|
|
-
|
Stock Option (right to buy) |
Design Therapeutics Inc
|
Arsani William
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
19,000 |
19,000
|
-
|
|
-
|
Stock Option (right to buy) |
Design Therapeutics Inc
|
Deepa Prasad
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
19,000 |
19,000
|
-
|
|
-
|
Stock Option (right to buy) |
Immunome Inc
|
Carol A. Schafer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,864 |
18,864
|
-
|
|
-
|
Director Stock Option (right to buy) |
Immunome Inc
|
Philip Wagenheim
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,864 |
18,864
|
-
|
|
-
|
Director Stock Option (right to buy) |
Immunome Inc
|
Isaac Barchas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,864 |
18,864
|
-
|
|
-
|
Director Stock Option (right to buy) |
Immunome Inc
|
James P. Boylan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,864 |
18,864
|
-
|
|
-
|
Director Stock Option (right to buy) |
Immunome Inc
|
Sandra M. Swain
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,864 |
18,864
|
-
|
|
-
|
Director Stock Option (right to buy) |
Lantern Pharma Inc
|
Leslie W. Kreis
|
Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 3.38 per share. |
10 Jun 2025 |
18,678 |
335,654
|
-
|
3.4 |
63,132
|
Common Stock |
ePlus Inc
|
Elaine D. Marion
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,543 |
58,589
(0%)
|
0%
|
|
0
|
Common Stock |
ePlus Inc
|
Darren S. Raiguel
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,543 |
58,982
(0%)
|
0%
|
|
0
|
Common Stock |
GATX Corp.
|
Thomas A. Ellman
|
EVP & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
18,500 |
0
|
-
|
|
-
|
2019 NQ Stock Option (Right to Buy) |
GATX Corp.
|
Thomas A. Ellman
|
EVP & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.53 per share. |
10 Jun 2025 |
18,500 |
52,758
(0%)
|
0%
|
71.5 |
1,323,213
|
Common Stock |
Zenas Biopharma Inc.
|
Patricia L. Allen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Zenas Biopharma Inc.
|
Patrick G. Enright
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Zenas Biopharma Inc.
|
Jake R. Nunn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Zenas Biopharma Inc.
|
John J. Orloff
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Zenas Biopharma Inc.
|
Hongbo Lu
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Zenas Biopharma Inc.
|
James P. Boylan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Procept BioRobotics Corp
|
Antal Desai
|
Director |
Sale of securities on an exchange or to another person at price $ 64.02 per share. |
10 Jun 2025 |
18,412 |
66,089
|
-
|
64.0 |
1,178,683
|
Common Stock |
SoFi Technologies Inc
|
G. Thompson Hutton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,388 |
18,388
|
-
|
|
-
|
Restricted Stock Unit |
SoFi Technologies Inc
|
John C.R. Hele
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,388 |
18,388
|
-
|
|
-
|
Restricted Stock Unit |
SoFi Technologies Inc
|
Clara Liang
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,388 |
18,388
|
-
|
|
-
|
Restricted Stock Unit |
SoFi Technologies Inc
|
Bashir Ruzwana
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,388 |
18,388
|
-
|
|
-
|
Restricted Stock Unit |
SoFi Technologies Inc
|
William A. Borden
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,388 |
18,388
|
-
|
|
-
|
Restricted Stock Unit |
SoFi Technologies Inc
|
Dana Green
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
18,388 |
18,388
|
-
|
|
-
|
Restricted Stock Unit |
Insmed Inc
|
S. Nicole Schaeffer
|
Chief People Strategy Officer |
Sale of securities on an exchange or to another person at price $ 92.73 per share. |
10 Jun 2025 |
18,319 |
135,188
(0%)
|
0%
|
92.7 |
1,698,721
|
Common Stock |
BGC Group Inc - Ordinary S...
|
Arthur U. Mbanefo
|
Director |
Sale of securities on an exchange or to another person at price $ 9.77 per share. |
10 Jun 2025 |
18,151 |
19,309
(0%)
|
0%
|
9.8 |
177,335
|
Class A Common Stock, par value $0.01 per share |
Metropolitan Bank Holding ...
|
Mark R. DeFazio
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 65.33 per share. |
10 Jun 2025 |
17,642 |
2,875
(0%)
|
0%
|
65.3 |
1,152,605
|
Common Stock |
Warby Parker Inc - Ordinar...
|
Ronald A. Williams
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
17,362 |
100,623
|
-
|
|
0
|
Class A Common Stock |
Upstream Bio Inc.
|
Ronald C. Renaud
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
17,096 |
17,096
|
-
|
|
-
|
Stock Option (Right to Buy) |
Upstream Bio Inc.
|
Daniella Beckman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
17,096 |
17,096
|
-
|
|
-
|
Stock Option (Right to Buy) |
Upstream Bio Inc.
|
Liam Ratcliffe
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
17,096 |
17,096
|
-
|
|
-
|
Stock Option (Right to Buy) |
Upstream Bio Inc.
|
Erez Chimovits
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
17,096 |
17,096
|
-
|
|
-
|
Stock Option (Right to Buy) |
Upstream Bio Inc.
|
H. Edward Fleming
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
17,096 |
17,096
|
-
|
|
-
|
Stock Option (Right to Buy) |
Upstream Bio Inc.
|
Marcella Kuhlman Ruddy
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
17,096 |
17,096
|
-
|
|
-
|
Stock Option (Right to Buy) |
e.l.f. Beauty Inc
|
Tarang P. Amin
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
16,950 |
228,037
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
e.l.f. Beauty Inc
|
Tarang P. Amin
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
16,950 |
81,818
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
e.l.f. Beauty Inc
|
Tarang P. Amin
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
16,950 |
228,037
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
e.l.f. Beauty Inc
|
Tarang P. Amin
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
10 Jun 2025 |
16,950 |
98,768
(0%)
|
0%
|
|
0
|
Common Stock, $0.01 par value |
Corcept Therapeutics Inc
|
William Guyer
|
Chief Development Officer |
Sale of securities on an exchange or to another person at price $ 72.36 per share. |
10 Jun 2025 |
16,918 |
8,569
(0%)
|
0%
|
72.4 |
1,224,261
|
Common Stock |
Direct Digital Holdings In...
|
Richard M. Cohen
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
16,462 |
0
|
-
|
|
-
|
Restricted Stock Units |
Direct Digital Holdings In...
|
Richard M. Cohen
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
16,462 |
72,367
|
-
|
|
-
|
Class A Common Stock, par value $0.001 per share |
Direct Digital Holdings In...
|
Antoinette R. Leatherberry
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
16,462 |
0
|
-
|
|
-
|
Restricted Stock Units |
Direct Digital Holdings In...
|
Antoinette R. Leatherberry
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
16,462 |
72,274
|
-
|
|
-
|
Class A Common Stock, par value $0.001 per share |
EverCommerce Inc
|
Eric Remer
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 10.29 per share. |
10 Jun 2025 |
16,409 |
5,421,754
|
-
|
10.3 |
168,865
|
Common Stock |
BeiGene Ltd - ADR
|
Xiaodong Wang
|
Director, Chair, Scientific Advisory Brd |
Sale of securities on an exchange or to another person at price $ 263.17 per share. |
10 Jun 2025 |
16,094 |
6,887
(0%)
|
0%
|
263.2 |
4,235,501
|
American Depositary Shares |
Warby Parker Inc - Ordinar...
|
Bradley E. Singer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
16,026 |
31,819
|
-
|
|
0
|
Class A Common Stock |
Warby Parker Inc - Ordinar...
|
Andrew Hunt
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
16,026 |
1,929,231
|
-
|
|
0
|
Class A Common Stock |
World Acceptance Corp.
|
John L. Calmes
|
See remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
16,000 |
55,395
(0%)
|
0%
|
|
0
|
COMMON STOCK, NO PAR VALUE |
BeiGene Ltd - ADR
|
Xiaodong Wang
|
Director, Chair, Scientific Advisory Brd |
Sale of securities on an exchange or to another person at price $ 262.20 per share. |
10 Jun 2025 |
15,878 |
22,981
(0%)
|
0%
|
262.2 |
4,163,262
|
American Depositary Shares |
Insmed Inc
|
Sara M. Bonstein
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 89.85 per share. |
10 Jun 2025 |
15,825 |
109,840
(0%)
|
0%
|
89.8 |
1,421,876
|
Common Stock |
Intellicheck Inc
|
Bryan Lewis
|
Director, CEO/President |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.53 per share. |
10 Jun 2025 |
15,607 |
389,018
(2%)
|
0%
|
2.5 |
39,486
|
Common Stock, $.001 par value |
Intellicheck Inc
|
Bryan Lewis
|
Director, CEO/President |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
15,607 |
18,443
|
-
|
|
-
|
Stock Option (Right to Buy) |
ClearPoint Neuro Inc
|
Joseph M. Burnett
|
Director, CEO and President |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.29 per share. |
10 Jun 2025 |
15,476 |
9,887
(0%)
|
0%
|
13.3 |
205,676
|
Common Stock |
Aveanna Healthcare Holding...
|
Deborah Stewart
|
SVP, Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 5.56 per share. |
10 Jun 2025 |
15,457 |
285,396
|
-
|
5.6 |
85,970
|
Common Stock, par value $0.01 per share |
Remitly Global Inc
|
Phillip J. Riese
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
15,239 |
117,496
|
-
|
|
-
|
Common Stock |
Remitly Global Inc
|
Phillip J. Riese
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
15,239 |
0
|
-
|
|
-
|
Restricted Stock Units (RSUs) |
Akero Therapeutics Inc
|
Andrew Cheng
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 54.35 per share. |
10 Jun 2025 |
15,158 |
564,324
(1%)
|
0%
|
54.4 |
823,883
|
Common Stock |
Cogent Communications Hold...
|
David Schaeffer
|
Director, CHAIRMAN, CEO, AND PRESIDENT |
Sale of securities on an exchange or to another person at price $ 48.63 per share. |
10 Jun 2025 |
15,000 |
3,591,721
(7%)
|
0%
|
48.6 |
729,494
|
common stock |
Big 5 Sporting Goods Corp
|
David R. Jessick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
15,000 |
199,793
(0%)
|
0%
|
|
0
|
Common Stock, par value $.01 |
Big 5 Sporting Goods Corp
|
Jennifer Holden Dunbar
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
15,000 |
120,751
(0%)
|
0%
|
|
0
|
Common Stock, par value $.01 |
Big 5 Sporting Goods Corp
|
Van B. Honeycutt
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
15,000 |
65,201
(0%)
|
0%
|
|
0
|
Common Stock, par value $.01 |
Big 5 Sporting Goods Corp
|
Colleen Birdnow Brown
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
15,000 |
60,951
(0%)
|
0%
|
|
0
|
Common Stock, par value $.01 |
Big 5 Sporting Goods Corp
|
Stephen Carley
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
15,000 |
59,951
(0%)
|
0%
|
|
0
|
Common Stock, par value $.01 |
Big 5 Sporting Goods Corp
|
Lily W. Chang
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
15,000 |
45,337
(0%)
|
0%
|
|
0
|
Common Stock, par value $.01 |
Yext Inc
|
Darryl Bond
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2025 |
15,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Yext Inc
|
Darryl Bond
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. |
10 Jun 2025 |
15,000 |
427,795
(0%)
|
0%
|
5 |
75,000
|
Common Stock |
Corcept Therapeutics Inc
|
David L. Mahoney
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
15,000 |
15,000
|
-
|
|
-
|
Stock option (right to buy) |
Corcept Therapeutics Inc
|
Daniel N. Swisher
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
15,000 |
15,000
|
-
|
|
-
|
Stock option (right to buy) |
Corcept Therapeutics Inc
|
George Leonard Baker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
15,000 |
15,000
|
-
|
|
-
|
Stock Option (Right To Buy) |
Corcept Therapeutics Inc
|
Gregg H. Alton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
15,000 |
15,000
|
-
|
|
-
|
Stock option (right to buy) |
Corcept Therapeutics Inc
|
Kimberly Park
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2025 |
15,000 |
15,000
|
-
|
|
-
|
Stock option (right to buy) |